BR9611520A - Composto hemo-reguladores. - Google Patents

Composto hemo-reguladores.

Info

Publication number
BR9611520A
BR9611520A BR9611520-3A BR9611520A BR9611520A BR 9611520 A BR9611520 A BR 9611520A BR 9611520 A BR9611520 A BR 9611520A BR 9611520 A BR9611520 A BR 9611520A
Authority
BR
Brazil
Prior art keywords
hemoregulatory
compound
fungal
viral
treatment
Prior art date
Application number
BR9611520-3A
Other languages
English (en)
Inventor
Pradip Kumar Bhatnagar
Dirk Andries Heerding
James Francis Callahan
Michael Hartmann
Johann Hiebl
Peter Kremminger
Franz Rovenszky
Original Assignee
Smithkline Beckman Corp
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp, Nycomed Imaging As filed Critical Smithkline Beckman Corp
Publication of BR9611520A publication Critical patent/BR9611520A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Microwave Amplifiers (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"COMPOSTOS HEMO-REGULADORES". A presente invenção refere-se a novos compostos que tem atividades hemo-reguladoras e podem ser usados para estimular a hematopoiese e para o tratamento de doenças infecciosas virais, fúngicas e bacterianas.
BR9611520-3A 1995-11-13 1996-11-12 Composto hemo-reguladores. BR9611520A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US657195P 1995-11-13 1995-11-13
US657395P 1995-11-13 1995-11-13
PCT/US1996/018126 WO1997017964A1 (en) 1995-11-13 1996-11-12 Hemoregulatory compounds

Publications (1)

Publication Number Publication Date
BR9611520A true BR9611520A (pt) 1999-12-28

Family

ID=26675804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611520-3A BR9611520A (pt) 1995-11-13 1996-11-12 Composto hemo-reguladores.

Country Status (15)

Country Link
EP (1) EP0861077B1 (pt)
JP (1) JP2000500751A (pt)
KR (1) KR19990067506A (pt)
CN (1) CN1209061A (pt)
AT (1) ATE212839T1 (pt)
AU (1) AU711239B2 (pt)
BR (1) BR9611520A (pt)
CZ (1) CZ147098A3 (pt)
DE (1) DE69619123D1 (pt)
IL (1) IL124354A0 (pt)
NO (1) NO310656B1 (pt)
NZ (1) NZ323207A (pt)
PL (1) PL326631A1 (pt)
TR (1) TR199800850T2 (pt)
WO (1) WO1997017964A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997017968A1 (en) * 1995-11-13 1997-05-22 Smithkline Beecham Corporation Hemoregulatory compounds
ATE261336T1 (de) * 1998-12-07 2004-03-15 Hoffmann La Roche Verfahren und vorrichtung zum mischen oder dispergieren von flüssigkeiten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917626A (en) * 1971-03-29 1975-11-04 Ici Ltd 3,6-Dioxa-1,8-octandiamido bis (pyridinium) compounds
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
US4544661A (en) * 1983-09-23 1985-10-01 Chevron Research Company Fungicidal N-pyridyloxy alkyl amines
JPH0381222A (ja) * 1989-08-22 1991-04-05 Yoshitomi Pharmaceut Ind Ltd 制癌剤
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
JPH09504266A (ja) * 1993-05-24 1997-04-28 スミスクライン・ビーチャム・コーポレイション 血液調節ペプチド

Also Published As

Publication number Publication date
NZ323207A (en) 1999-11-29
EP0861077A4 (en) 1999-03-03
AU711239B2 (en) 1999-10-07
NO982151L (no) 1998-07-03
PL326631A1 (en) 1998-10-12
CZ147098A3 (cs) 1999-02-17
JP2000500751A (ja) 2000-01-25
NO310656B1 (no) 2001-08-06
EP0861077A1 (en) 1998-09-02
DE69619123D1 (de) 2002-03-21
WO1997017964A1 (en) 1997-05-22
AU7728296A (en) 1997-06-05
KR19990067506A (ko) 1999-08-25
TR199800850T2 (xx) 1998-09-21
EP0861077B1 (en) 2002-02-06
NO982151D0 (no) 1998-05-12
IL124354A0 (en) 1998-12-06
CN1209061A (zh) 1999-02-24
ATE212839T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
PE13396A1 (es) Compuesto biciclico
FI963070A (fi) Klooripyrimidiinivälituotteita
DK1200418T3 (da) Nematodicide trifluorbutener
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
HUT76511A (en) Benzoyl derivatives, preparation and use thereot
AP9200410A0 (en) Retroviral protease inhibitors.
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
ES2159287T3 (es) Peptidos hemorreguladores.
BR9611520A (pt) Composto hemo-reguladores.
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
AU6722498A (en) Disubstituted biphenyloxazolines
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law